跳至主要内容
临床试验/NCT02558335
NCT02558335已完成不适用

Circulating Tumor Markers for High Grade Glioma

Abramson Cancer Center at Penn Medicine1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
to identify and quantify circulating tumor markers

研究概览

简要总结

The purpose of this study is to identify and quantify circulating tumor markers, which are associated with the presence of tumors. The current imaging available does not allow specificity of tumor size as it relates to pseudoprogression (a temporary enlargement or "swelling" of the tumor after treatment before it shrinks). Our hope is that CTCs will provide a more accurate description of tumor state for high grade glioma patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with biopsy-proven high grade glioma who are undergoing definitive radiotherapy as a part of their treatment regimen or patients with radiographic appearance of high grade glioma
  • Age 18 or older
  • Signed informed consent

排除标准

  • 未提供

结局指标

主要结局

to identify and quantify circulating tumor markers

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验